| NRHIX | RITEX | NRHIX / RITEX | |
| Total Expense Ratio | 0.61 | 0.70 | 87% |
| Annual Report Gross Expense Ratio | 0.61 | 0.70 | 87% |
| Fund Existence | 13 years | 23 years | - |
| Gain YTD | 7.497 | 7.197 | 104% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 517M | 26.4B | 2% |
| Annual Yield % from dividends | 6.72 | 6.29 | 107% |
| Returns for 1 year | 8.12 | 7.67 | 106% |
| Returns for 3 years | 29.20 | 31.50 | 93% |
| Returns for 5 years | 21.38 | 30.94 | 69% |
| Returns for 10 years | 73.31 | 89.94 | 82% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TLTE | 63.94 | 0.33 | +0.52% |
| FlexShares Mstar EmgMkts FctTilt ETF | |||
| ACLO | 50.26 | 0.01 | +0.03% |
| TCW AAA CLO ETF | |||
| IBTF | 23.30 | N/A | N/A |
| iShares iBonds Dec 2025 Term Treasury ETF | |||
| SAGP | 35.24 | -0.04 | -0.11% |
| Strategas Global Policy Opp ETF | |||
| MSSM | 51.54 | -0.13 | -0.25% |
| Morgan Stanley Pathway Sm-Md Cp Eq ETF | |||